Search Results

Positron Corporation (“Positron” or the “Company”) (OTC: POSC) is pleased to announce it has entered an agreement to acquire the FDA 510(k) for the NeuSight PET-CT from its cooperative partner Neusoft Medical Systems’ subsidiary, Shenyang Intelligent Neuclear Medical Technology Co.

Positron Corporation is pleased to announce that it has ordered five NeuSight PET-CT 64 slice scanners from cooperative partner Neusoft Medical Systems’ subsidiary, Shenyang Intelligent Neuclear Medical Technology Co.

Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT imaging systems and clinical services, is pleased to announce its membership in the national alliance “Cardiac PET Industry Coalition”, an organization at the forefront of quality of patient care, advocacy and innovation to advance the field of cardiovascular PET imaging.

Positron Corporation (“Positron” or the “Company”) (OTC: POSC) is pleased to announce it has secured exclusive rights for the North American market to sell/distribute the NeuSight PET-CT 64 slice scanner through a business cooperation agreement with Neusoft Medical Systems’ subsidiary, Shenyang Intelligent Neuclear Medical Technology Co.

Positron Corporation is pleased to welcome a prominent cardiovascular practice in Pennsylvania as a new customer utilizing Positron’s Attrius® PET System and services.

Positron Corporation, a leading molecular imaging medical device company offering PET imaging systems and clinical services, is pleased to welcome a prominent cardiovascular practice in California as a new customer utilizing Positron’s Attrius® PET System and services.